Back to Journals » ClinicoEconomics and Outcomes Research » Volume 13

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain

Total article views   HTML views PDF downloads Totals
5,295 Dovepress* 4,842+ 613 5,455
PubMed Central* 453 134 587
Totals 5,295 747 6,042
*Since 22 April 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar